Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

被引:27
|
作者
Tomii, Yasuhiro [1 ]
Toyoda, Kazunori [1 ]
Nakashima, Takahiro [1 ]
Nezu, Tomohisa [1 ]
Koga, Masatoshi [2 ]
Yokota, Chiaki [1 ]
Nagatsuka, Kazuyuki [3 ]
Minematsu, Kazuo [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan
基金
日本学术振兴会;
关键词
blood pressure; heart rate; hypertension; outcome; stroke; thrombolysis; tissue plasminogen activator; ACUTE ISCHEMIC-STROKE; SAFE IMPLEMENTATION; PROGNOSTIC-SIGNIFICANCE; DIFFERENT SUBTYPES; CLINICAL-TRIAL; THROMBOLYSIS; ALTEPLASE; ASSOCIATION; VARIABILITY; PREDICTORS;
D O I
10.1097/HJH.0b013e32834a764e
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background and purpose The present study clarifies associations between stroke outcomes after intravenous tissue plasminogen activator (tPA) and blood pressure (BP) as well as heart rate (HR) profiles. Methods We assessed 125 patients with stroke who received tPA within 3 h of onset. We obtained baseline, mean, maximum, minimum, and coefficient of variation values for BP and HR during the initial 24 h. The primary outcome was independence at 3 months corresponding to a modified Rankin Scale score of 2 or less. The secondary outcomes were early neurological improvement at 24 h and intracerebral hemorrhage (ICH) within 36 h. Results Among the patients, 64 (51%) achieved independence, 66 (53%) early improvement, and 26 (21%) developed ICH. The 24-h time courses of SBP (P = 0.033), pulse pressure (PP, P = 0.007), and HR (P < 0.001) were lower among patients who reached independence than among those who did not. After multivariate adjustment, 24-h mean levels of SBP (odds ratio 0.69, 95% confidence interval 0.48-0.97, per 10-mmHg increase), PP (0.63, 0.41-0.94), and HR (0.59, 0.42-0.80, per 10-bpm increase) were inversely associated with independence, as were their maximum and minimum values. In particular, mean SBP values were inversely associated with independence at 8-16 and 16-24 h (0.73, 0.54-0.97 and 0.66, 0.47-0.91, respectively), but not at 0-8 h (0.79, 0.57-1.07). Baseline and maximum SBP were inversely associated with early improvement. Maximum and coefficient of variation of SBP were associated with ICH. Conclusion Lower SBP, PP, and HR values during the initial 24 h after tPA, especially at 8 h thereafter, were associated with independence at 3 months. J Hypertens 29:1980-1987 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1980 / 1987
页数:8
相关论文
共 50 条
  • [1] Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator
    Huang Yin-hui
    Zhuo Shi-tu
    Chen Ya-fang
    Li Ming-mei
    Lin You-yu
    Yang Mei-li
    Chen Zhen-jie
    Cai Ruo-wei
    CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4685 - 4690
  • [2] Safety and Outcomes in Stroke Mimics after Intravenous Tissue Plasminogen Activator Administration: A Single-center Experience
    Lewandowski, Christopher
    Mays-Wilson, Kathleen
    Miller, Joseph
    Penstone, Patricia
    Miller, Daniel J.
    Bakoulas, Konstandinos
    Mitsias, Panayiotis
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (01) : 48 - 52
  • [3] Hourly blood pressure monitoring after intravenous tissue plasminogen activator for ischemic stroke - Does everyone need it?
    Aiyagari, V
    Gujjar, A
    Zazulia, AR
    Diringer, MN
    STROKE, 2004, 35 (10) : 2326 - 2330
  • [4] Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke
    Yoneda, Yukihiro
    Yamamoto, Shinji
    Hara, Yoshie
    Yamashita, Haruo
    CASE REPORTS IN NEUROLOGY, 2009, 1 (01): : 20 - 23
  • [5] Outcomes of Endovascular Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator for the Treatment of Vertebrobasilar Stroke
    Brinjikji, Waleed
    Rabinstein, Alejandro A.
    Cloft, Harry J.
    JOURNAL OF CLINICAL NEUROLOGY, 2014, 10 (01): : 17 - 23
  • [6] Early Changes of Tissue Perfusion After Tissue Plasminogen Activator in Hyperacute Ischemic Stroke
    An, Hongyu
    Ford, Andria L.
    Vo, Katie
    Eldeniz, Cihat
    Ponisio, Rosana
    Zhu, Hongtu
    Li, Yimei
    Chen, Yasheng
    Powers, William J.
    Lee, Jin-Moo
    Lin, Weili
    STROKE, 2011, 42 (01) : 65 - 72
  • [7] Pre-Tissue Plasminogen Activator Blood Pressure Levels and Risk of Symptomatic Intracerebral Hemorrhage
    Tsivgoulis, Georgios
    Frey, James L.
    Flaster, Murray
    Sharma, Vijay K.
    Lao, Annabelle Y.
    Hoover, Steven L.
    Liu, Wei
    Stamboulis, Elefterios
    Alexandrov, Anne W.
    Malkoff, Marc D.
    Alexandrov, Andrei V.
    STROKE, 2009, 40 (11) : 3631 - 3634
  • [8] Decompressive craniectomy after intravenous tissue plasminogen activator administration for stroke
    Takeuchi, Satoru
    Wada, Kojiro
    Nawashiro, Hiroshi
    Arimoto, Hirohiko
    Ohkawa, Hidenori
    Masaoka, Hiroyuki
    Otani, Naoki
    Takasato, Yoshio
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (10) : 1312 - 1315
  • [9] Intravenous Tissue Plasminogen Activator for Patients with Minor Ischemic Stroke
    Huisa, Branko N.
    Raman, Rema
    Neil, Will
    Ernstrom, Karin
    Hemmen, Thomas M.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08) : 732 - 736
  • [10] Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke
    Zhou, Xiao-Yu
    Wang, Shao-Shi
    Collins, Marnie L.
    Davis, Stephen M.
    Yan, Bernard
    JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (08) : 988 - 992